Filing Flows › IDEX (IEX) › Q2 2026 › vs Q2 2025
IDEX (IEX) Q2 2026 vs Q2 2025 (year over year)
IDEX's revenue rose $55.2M (+6%) from $865M in Q2 2025 to $921M in Q2 2026. The biggest changes: Health & Science Technologies +$50.1M (+14%); Fluid & Metering Technologies +$6.2M (+2%); Fire & Safety/Diversified Products −$1.1M (-0.6%). Gross margin 46.4% against 45.3% (+1.0 pts).
IDEX, Q2 2026: revenue $921M (+6% year over year), operating margin 21.7%, net earnings $143M, operating cash flow $200M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 46.4% | 45.3% | +1.0 pts |
| Operating margin | 21.7% | 21.7% | +0.0 pts |
| Net margin | 15.6% | 15.1% | +0.4 pts |
| Free cash flow margin | 19.2% | 17.0% | +2.3 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Health & Science Technologies | $414M | $364M | $50.1M | +14% |
| Fluid & Metering Technologies | $317M | $310M | $6.2M | +2% |
| Fire & Safety/Diversified Products | $190M | $191M | −$1.1M | -0.6% |
| Revenue | $921M | $865M | $55.2M | +6% |
| Gross profit | $427M | $392M | $34.6M | +9% |
| Cost of revenue | $494M | $473M | $20.6M | +4% |
| Operating profit | $200M | $188M | $12.0M | +6% |
| Operating expenses | $227M | $204M | $22.6M | +11% |
| Pre-tax earnings | $186M | $170M | $16.2M | +10% |
| Other expense, net | $13.8M | $18.0M | −$4.2M | -23% |
| SG&A | $224M | $204M | $20.5M | +10% |
| Other operating costs | $2.8M | $700K | $2.1M | +300% |
| Net earnings | $143M | $131M | $12.3M | +9% |
| Income tax | $42.7M | $38.8M | $3.9M | +10% |
| Depreciation & amortization | $53.4M | $51.0M | $2.4M | +5% |
| Share-based compensation | $6.1M | $5.2M | $900K | +17% |
| Working capital & other | $2.9M | $25.6M | −$22.7M | -89% |
| Operating cash flow | $200M | $162M | $38.3M | +24% |
| Free cash flow (company-reported) | $177M | $147M | $30.1M | +20% |
| Capital expenditures | $23.0M | $14.8M | $8.2M | +55% |
Questions
How much did IDEX's revenue grow year over year in Q2 2026?
IDEX's revenue rose $55.2M (+6%) from $865M in Q2 2025 to $921M in Q2 2026.
What drove IDEX's revenue change in Q2 2026?
Health & Science Technologies +$50.1M (+14%); Fluid & Metering Technologies +$6.2M (+2%); Fire & Safety/Diversified Products −$1.1M (-0.6%).